Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S (COLO B)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Coloplast A/S : Patent Issued for Method of Implanting a Penile Prosthetic (USPTO 9636225)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2017 | 09:04pm CEST

By a News Reporter-Staff News Editor at Journal of Engineering -- According to news reporting originating from Alexandria, Virginia, by VerticalNews journalists, a patent by the inventors Daniel, Geoffrey A. (Crystal, MN); Tropsha, Yelena (Plymouth, MN), filed on April 21, 2016, was published online on May 2, 2017.

The assignee for this patent, patent number 9636225, is Coloplast A/S (Humlebaek, DE).

Reporters obtained the following quote from the background information supplied by the inventors: "An implanted penile prosthetic is effective in relieving erectile dysfunction in men.

"An inflatable penile prosthetic typically includes a cylinder that is implanted in each corpora cavernosum of the penis, a fluid reservoir, and a pump with valve mechanisms to move fluid from the reservoir to the cylinder to create an erection in the penis. Other penile prosthetics include a malleable cylinder without inflation fluid.

"Placement of a cylinder in the corpora cavernosum in a typical surgical procedure includes dilating the corpora cavernosum with a dilation tool to form an implant space sized to receive the cylinder. The cylinder is introduced into the implant space with a needle and a suture. One end of the suture is attached to the leading end of the cylinder and an opposite end of the suture is attached to a Keith needle. The Keith needle is directed through the glans penis and the cylinder is pulled distally towards the glans penis inside the corpora cavernosum.

"The above-described penile prosthetics have proven effective in relieving erectile dysfunction in men. However, improvements to penile prostheses would be welcomed by surgeons and patients alike."

In addition to obtaining background information on this patent, VerticalNews editors also obtained the inventors' summary information for this patent: "One aspect provides a penile prosthetic including a cylinder that is implantable into a corpora cavernosum of a penis. A resorbable suture-engagement component is attached to an exterior surface of the cylinder.

"One aspect provides an implantable penile prosthetic system including a pump attachable between a reservoir and an inflatable cylinder. The cylinder is configured to be placed in a corpora cavernosum of a penis. A resorbable suture-engagement component is attached to an exterior surface of the cylinder.

"One aspect provides a penile prosthetic including a cylinder that is implantable into a corpora cavernosum of a penis, the cylinder having a wall that forms an exterior surface of the penile prosthetic. The wall extends from a proximal end portion to a distal end portion of the penile prosthetic. A suture-engaging component is attached to the exterior surface of the penile prosthetic. The suture-engaging component is resorbable into the tissue of the penis."

For more information, see this patent: Daniel, Geoffrey A.; Tropsha, Yelena. Method of Implanting a Penile Prosthetic. U.S. Patent Number 9636225, filed April 21, 2016, and published online on May 2, 2017. Patent URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9636225.PN.&OS=PN/9636225RS=PN/9636225

Keywords for this news article include: Impotence, Men's Health, Coloplast A/S, Erectile Dysfunction, Male Genital Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Science Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COLOPLAST A/S
05/11 COLOPLAST A/S : Patent Issued for Method of Implanting a Penile Prosthetic (USPT..
05/11 COLOPLAST A/S : Patent Issued for Fistula Plug Comprising ECM (USPTO 9636438)
05/08 COLOPLAST A/S : ex-dividend day for interim dividend
05/04 COLOPLAST A/S : delivers satisfactory Q2 result
04/28COLOPLAST A/S : half-yearly earnings release
04/20 COLOPLAST A/S : Patent Issued for Sacrocolpopexy Support (USPTO 9615904)
04/07 COLOPLAST A/S : Patent Issued for Needle Handling Device and a Method for Implan..
03/22 COLOPLAST A/S : Presolicitation Notice - Sypnosis of Coloplast Prosthesis Implan..
03/02 COLOPLAST A/S : Patent Issued for Multi-Layered Adhesive Appliance (USPTO 957270..
02/23 COLOPLAST A/S : 02/2017 Share buy-back programme
More news
Sector news : Medical Equipment Wholesale
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/16 Earnings drag on European shares, though Vodafone lifts telcos
05/09 French outbound M&A driven to decade high by big deals
05/06DJProfits Jump, Spending Lags -- WSJ
More sector news : Medical Equipment Wholesale
News from SeekingAlpha
05/03 Coloplast's (CLPBF) CEO Lars Rasmussen on Q2 2017 Results - Earnings Call Tra..
05/03 Coloplast ASB reports Q2 results
02/01 Coloplast ASB 2017 Q1 - Results - Earnings Call Slides
02/01 Coloplast's (CLPBF) CEO Lars Rasmussen on Q1 2016/17 Results - Earnings Call ..
02/01 Coloplast ASB beats on revenue
Advertisement
Financials ( DKK)
Sales 2017 15 788 M
EBIT 2017 5 215 M
Net income 2017 3 929 M
Debt 2017 1 087 M
Yield 2017 2,52%
P/E ratio 2017 29,91
P/E ratio 2018 26,86
EV / Sales 2017 7,07x
EV / Sales 2018 6,54x
Capitalization 110 484 M
More Financials
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | 4-Traders
Full-screen chart
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 541  DKK
Spread / Average Target -3,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Søren Rasmussen President & Chief Executive Officer
Michael Pram Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard CFO, Executive VP & Head-Investor Relations
Oliver Johansen Senior VP-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S17.57%16 499
HENRY SCHEIN, INC.20.03%14 351
PATTERSON COMPANIES, I..4.97%4 224
AMPLIFON SPA38.78%3 130
CANTEL MEDICAL CORP.-5.14%3 033
OWENS & MINOR, INC.-8.64%1 959
More Results